Annotated Medicine and Device Lists

Hydralazine

This medicine is present in:

List Section Observation
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives Others observations:
Only for treatment of pregnancy-induced hypertension and resistant hypertension

This medicine is present in:

List Section Observation
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 1.4.1 Vasodilators No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
AMP X 1 ML CAJA X 5 AMPULAS
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
El Salvador - 2019 ANTIHIPERTENSIVOS No observations
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: FORMAS FARMACÉUTICAS DE ADMINISTRACIÓN PARENTERAL

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Ecuador Essential Medicines List - Ecuador No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations
Belize. National Drug Formulary 12.03 Antihypertensive medicines No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 02.05.01 Vasodilator Antihypertensive Drugs No observations

This medicine is present in:

List Section Observation
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations
Guyana. Essential Medicines List. 2020-2021 15.02.07. Vasodilators No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Suriname. NGK-C-011 12.3 Antihypertensives No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.08.20 Direct Vasodilator No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines No observations
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 1.4.1 Vasodilators No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.08.20 Direct Vasodilator No observations
Belize. National Drug Formulary 12.03 Antihypertensive medicines No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 12.3. Antihypertensive medicines Others observations:
Hydralazine is listed for use in the acute management of severe pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of more evidence of efficacy and safety of other medicines.
PAHO Strategic Fund Medicine List 6.1. Antihypertensive medicines Others observations:
Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.
Ecuador Essential Medicines List - Ecuador No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. Others observations:
X 30 TBS
El Salvador - 2019 ANTIHIPERTENSIVOS No observations
Chile. Formulario Nacional de Medicamentos. 2005 11.03. ANTIHIPERTENSIVOS No observations
Suriname. NGK-C-011 12.3 Antihypertensives No observations
Barbados. Barbados National Drug Formulary (BNDF) 24.08.20 Direct Vasodilator No observations

This medicine is present in:

List Section Observation
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 C. APARELHO CARDIOVASCULAR No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives Others observations:
Only for treatment of pregnancy-induced hypertension and resistant hypertension
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations

This medicine is present in:

List Section Observation
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cvs Vasodilators-Antihypertensive No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 C. APARELHO CARDIOVASCULAR No observations
Guyana. Essential Medicines List. 2020-2021 15.02.07. Vasodilators No observations
Organisation of Eastern Caribbean States. Medical Products List. 2019-2021 24:08 Anti-hypertensive agents No observations
Haiti. National List of Essential Medicines 12.03 Anti-hypertensives Others observations:
Only for treatment of pregnancy-induced hypertension and resistant hypertension
Bahamas. Drug Formulary 02. CARDIOVASCULAR DRUGS No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 02.05.01 Vasodilator Antihypertensive Drugs No observations

This medicine is present in:

List Section Observation
Costa Rica. Caja Costarricense de Seguro Social. 2019 08. Antihipertensivos No observations
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations
Mexico. Cuadro Basico de Medicamentos - 2017 03. CARDIOLOGIA No observations

Information Resources: Hydralazine